☆ 4.6 Letter

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Related references

Note: Only part of the references are listed.
Letter Surgery

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm

Sherif Beniameen Mossad

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Add to Collection
Article Urology & Nephrology

Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis

Ayelet Grupper et al.

Summary: Patients on maintenance hemodialysis showed a significantly lower humoral response following the BNT162b2 vaccine compared to the control group, with age being an important factor in the humoral response.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection
Article Infectious Diseases

Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)

Julien Favresse et al.

Summary: The CRO-VAX HCP study investigated the early antibody response in healthcare professionals who received two doses of the BNT162b2 mRNA COVID-19 vaccine. Results showed that in previously infected individuals, a single dose of the vaccine may be sufficient, as they had higher antibody titres compared to uninfected individuals.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection
Letter Urology & Nephrology

Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients

Noa Berar Yanay et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.